Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib

BACKGROUND: The ‘Prediction Of Survival in Advanced Sorafenib‐treated HCC’ (PROSASH) model addressed the heterogeneous survival of patients with hepatocellular carcinoma (HCC) treated with sorafenib in clinical trials but requires validation in daily clinical practice. This study aimed to validate,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Liver Int
Egile Nagusiak: Labeur, Tim A., Berhane, Sarah, Edeline, Julien, Blanc, Jean‐Frederic, Bettinger, Dominik, Meyer, Tim, Van Vugt, Jeroen L. A., Ten Cate, David W. G., De Man, Robert A., Eskens, Ferry A. L. M., Cucchetti, Alessandro, Bonnett, Laura J., Van Delden, Otto M., Klümpen, Heinz‐Josef, Takkenberg, R. Bart, Johnson, Philip J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Liver Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6973249/
https://ncbi.nlm.nih.gov/pubmed/31579990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14270
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak